Navigation Links
Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators
Date:7/11/2014

New York, NY (PRWEB) July 11, 2014

As part of its morcellator lawsuit (http://www.gynecaremorcellatorlawsuit.com/) investigation, Bernstein Liebhard LLP has been closely monitoring the ongoing meeting of the U.S. Food & Drug Administration’s (FDA) Obstetrics and Gynecology Devices Panel, which has been convened to explore ways to mitigate the cancer risks associated with the use of power morcellators in minimally invasive gynecological surgeries. According to a report published by Dow Jones Business News, a number of panel members have financial relationships with medical device companies that market power morcellators. One of those individuals, Dr. Andrew Brill, removed himself from the Panel two days before the meeting began, after the FDA reviewed more than $100,000 in fees he received from Johnson & Johnson’s Ethicon, Inc. unit. At least two other gynecologists on the panel have also had financial relationships with manufacturers, according to the report.*

“This Panel will make recommendations that could have financial consequences for companies that market power morcellators. It is important to avoid even the appearance of conflicts-of-interest among its members,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating morcellator lawsuits on behalf of women who may have experienced the upstaging of uterine sarcoma and other cancers due to uterine morcellation.

Morcellator Cancer Dangers
Power morcellators are used during laparoscopic hysterectomy and fibroid removals to shred tissue in order to facilitate its removal through a small abdominal incision. The FDA meeting, which continues today in Silver Spring, Maryland, is part of the agency’s ongoing review of cancer risks associated with the devices. In April, the FDA issued an alert discouraging doctors from using the devices in minimally invasive gynecological surgeries due to the potential that they can disseminate undetected uterine cancer cells into the peritoneal cavity. According to the agency, about 1 in 350 women undergoing fibroid removal has undetected cancer cells in their fibroids, and dissemination of these cells via morcellation can greatly reduce a patient’s odds of long-term survival.

Following the issuance of the FDA alert, Ethicon announced it would suspend sales of its Gynecare Morcellex,Morcellex Sigma Tissue Morcellator System, and Gynecare X-Tract Tissue Morcellator products pending further guidance from the agency.* A number of hospitals, including the Cleveland Clinic, have also moved to ban or limit the technique until the FDA completes its review.**

Victims of uterine cancer that was allegedly spread via a power morcellator may be eligible for compensation. To learn more about filing a morcellator lawsuit, please visit Bernstein Liebhard LLP's website. Free case reviews can also be obtained by calling 800-511-5092.

*http://www.nasdaq.com/article/doctor-quits-uterine-device-safety-panel-over-conflict-20140710-00793, Dow Jones News Service, July 10, 2014
**reuters.com/article/2014/04/30/us-johnson-johnson-device-idUSKBN0DG06G20140430, Reuters, April 30, 2014
***cleveland.com/healthfit/index.ssf/2014/04/surgical_tool_for_hysterectomy.html, Cleveland Plain Dealer, April 28, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.gynecaremorcellatorlawsuit.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/uterine-sarcoma/prweb12012324.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments
2. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
3. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
4. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
5. Best Transvaginal Mesh Attorneys? LawsuitLegal.com Now Accepting Surgical Mesh Failure Victim Inquiries
6. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Recall Litigation
7. Pradaxa Lawsuits Move Forward, as Federal Litigation Schedules January Status Conference, Bernstein Liebhard LLP Reports
8. Fosamax Lawsuits: Bellwether Trials Scheduled in Federal, State Fosamax Femur Fracture Litigations, Bernstein Liebhard LLP Reports
9. Class Action Lawsuit Filed on Behalf of West Virginia Residents Affected by Recent Chemical Spill
10. West Virginia Business Owners Represented in Class Action Lawsuit over Elk River Chemical Spill
11. Transvaginal Mesh Lawsuit News: Bellwether Trial in Federal C.R. Bard Vaginal Mesh Litigation Postponed, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... On November 24th, ... families from eight different sites throughout Miami-Dade and Broward counties. This is the ... very hard on Thanksgiving morning by putting together individual meals via assembly lines ...
(Date:12/2/2016)... ... , ... ‘Tis the season for giving! Today, 20 creative teams across the ... and the Drug Enforcement Administration as part of the National Red Ribbon Week Photo ... who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. Be Drug ...
(Date:11/30/2016)... , ... November 30, 2016 , ... "I hate when ... arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that ... develop this handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and ...
(Date:11/30/2016)... ... 30, 2016 , ... Center For Discovery, a nationally recognized ... a new residential mental health treatment program in Chino Hills, California.  The California facility ... anxiety, depression, bi-polar disorder, and other related issues. , Center For Discovery is ...
(Date:11/30/2016)... ... November 30, 2016 , ... The Clinical ... that the FDA Binding Guidance goes into effect next month. Sponsors whose studies ... the FDA Data Standards Catalog. The current FDA Data Standards Catalog specifies the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec 2, 2016 Research and ... Size, Share, Development, Growth and Demand Forecast to 2022" report to ... , , ... of $6 billion in 2015, and it is expected to grow at ... segment is expected to witness faster growth during the forecast period, a ...
(Date:12/2/2016)... CORDOBA, Spain , Dec. 2, 2016 ... additional natural sources apart from those derived from C. ... Córdoba, the Universita` di Napoli Federico II , ... have created the first comprehensive, critical, integrated and unified ... The article focuses on the remarkable chemical ...
(Date:12/2/2016)... Dec. 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), ... Specialties, Inc. ("PSI").  The combination of Texas ... -based PSI bring together both company,s clinical expertise and ... payers an industry-leading specialty pharmacy. About Maxor ... , , ...
Breaking Medicine Technology: